Read + Share
Amedeo Smart
Independent Medical Education
DeVries JH, Irs A, Hillege HL. The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients. Eur Heart J 2023;44:3492-3494.PMID: 37482673
Email
LinkedIn
Facebook
Twitter
Privacy Policy